By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vitae Pharmaceuticals, Inc. 

502 West Office Center Drive

Fort Washington  Pennsylvania  19034  U.S.A.
Phone: 215-461-2000 Fax: 215-461-2006


Company News
Vitae Pharma (VTAE) Appoints Dr. Karen Bernstein To Board Of Directors 10/1/2015 7:42:57 AM
Vitae Pharma (VTAE) Initiates Second Part Of A Phase I Multiple Ascending Dose Study Of VTP-43742 In Psoriatic Patients 9/29/2015 6:52:06 AM
Vitae Pharma (VTAE) To Ring The NASDAQ Stock Market Closing Bell 9/22/2015 7:53:46 AM
Vitae Pharma (VTAE) Announces Positive Top-Line Results From Initial Phase 1 Study Of First-In-Class Roryt Inhibitor VTP-43742 In Autoimmune Disorders 9/9/2015 6:14:40 AM
Vitae Pharma (VTAE) Announces Initiation Of A Phase I Multiple Ascending Dose Study Of VTP-43742 In Autoimmune Disorders 8/11/2015 7:42:29 AM
Vitae Pharma (VTAE) Reports Second Quarter 2015 Operating And Financial Results 8/5/2015 7:47:46 AM
Vitae Pharma (VTAE) Appoints Dr. John M. Leonard To Board Of Directors 7/30/2015 7:02:46 AM
Vitae Pharma (VTAE) To Announce Second Quarter 2015 Financial Results On August 4, 2015 7/28/2015 7:54:58 AM
Embattled Vitae Pharma (VTAE) and Boehringer Ingelheim Relationship Takes Another Blow, Drops BACE Inhibitor Program for Alzheimer’s 7/27/2015 6:03:57 AM
Vitae Pharma (VTAE)’ Diabetes Drug Fails Mid-Stage Trial, the Second Drug in Less Than Six Months to Fail 6/29/2015 8:08:20 AM